Zoetis Inc (ZTS) Stock Price Today
Kyowa Kirin adopts AI platform Benchling to boost drug research efficiency in Japan.
Kyowa Kirin, a global specialty pharmaceutical company, is implementing the AI platform Benchling at its Tokyo and Fuji Research Parks to enhance research and development. Supported by Cognizant, Benchling will automate workflows, integrate data mana...
Capital One's Series I preferred shares stand out for dividends amid stable loan growth and strong credit health.
Capital One Financial offers five preferred share options, with Series I preferred shares favored for their higher dividend yield and lower sensitivity to interest rates. The bank's acquisition of Discover Financial has been smoothly integrated, supp...
Eaton Vance Tax-Managed Buy-Write Fund offers 8.19% yield with tech focus, trades at 7% discount amid cautious outlook.
The Eaton Vance Tax-Managed Buy-Write Opportunity Fund (ETV) provides investors with tech-heavy exposure and a monthly distribution yield of 8.19%. It currently trades at a 6.97% discount, which may attract income-focused investors. ETV employs an ag...
Top investors Tepper adds to NVIDIA, Loeb exits, Soros hedges with puts amid mixed views.
In Q2 2026, three leading investors showed contrasting moves on NVIDIA: David Tepper increased his stake, signaling confidence in AI growth; Dan Loeb fully exited, reallocating to Alphabet; George Soros hedged his large long position by buying puts, ...
NVIDIA and SpaceX form a $500B partnership to build massive AI computing infrastructure by 2027.
NVIDIA and SpaceX have announced a strategic partnership to build a massive AI computing infrastructure, targeting 10 gigawatts of AI compute capacity by 2027. SpaceX will use NVIDIA's GPUs exclusively, with NVIDIA backing a $500 billion financing pl...
Top hedge funds shift from Broadcom to Taiwan Semiconductor amid AI chip growth.
In Q2 filings, major hedge funds like David Tepper's Appaloosa, Dan Loeb's Third Point, and Stanley Druckenmiller's Duquesne Family Office significantly increased holdings in Taiwan Semiconductor Manufacturing (TSMC) while reducing or exiting positio...
Alnylam cuts 2026 sales forecast, shares drop over 28%, investors face potential losses
Alnylam Pharmaceuticals lowered its full-year 2026 sales guidance by about $200 million due to slower growth after initial demand in the ATTR-CM market. This announcement led to a sharp drop in its stock price by more than 28%, causing significant lo...
Baupost Group fully exits Vaxcyte and Willis Towers Watson in Q2, signaling a shift from recent biotech bets.
Seth Klarman's Baupost Group sold all its shares in Vaxcyte and Willis Towers Watson during Q2 2026, exiting positions it had only recently established. The move reflects a quick change in risk appetite, especially for Vaxcyte, a clinical-stage biote...
Beef prices soar due to smallest US cattle herd in 75 years, recovery not expected until 2028-2029
US beef prices have surged by about 23% due to the smallest cattle herd in 75 years, currently at 86.2 million head, down from 94.7 million in 2019. Persistent drought has forced ranchers to reduce their herds, including breeding cows, delaying recov...
SK Hynix approves $38B memory fabs, chips won't be ready until December 2028
SK Hynix has approved a $38 billion investment to build new memory fabrication plants. However, these new fabs are not expected to produce any chips before December 2028, indicating a long-term expansion plan. This move highlights SK Hynix's commitme...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.